Form 4 for IONS IONIS PHARMACEUTICALS INC
Accepted 2023-10-16 00:00:00 ET · period of report 2023-10-12 · accession 0000874015-23-000201 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-10-16 | 2023-10-12 | IONS | Monia Brett P | CEO, Dir | S - Sale | $46.00 | -3,770 | 118.1K | -3% | -$173.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-10-12 | S | D | 3,770 | $46.00 | 118,111 | D | — | — | (F1) Shares sold pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on July 13, 2023 |